Investing.com - ICU Medical (NASDAQ: ICUI) reported second quarter EPS of $1.56, $0.56 better than the analyst estimate of $1.00. Revenue for the quarter came in at $596.5M versus the consensus estimate of $553.74M.
Guidance
ICU Medical sees FY 2024 EPS of $4.95-$5.35 versus the analyst consensus of $4.83.
ICU Medical's stock price closed at $121.79. It is up 13.72% in the last 3 months and down -14.83% in the last 12 months.
ICU Medical saw 1 positive EPS revisions and 0 negative EPS revisions in the last 90 days. See ICU Medical's stock price’s past reactions to earnings here.
According to InvestingPro, ICU Medical's Financial Health score is "good performance".
Check out ICU Medical's recent earnings performance, and ICU Medical's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar
ICUI: A Bull or Bear Market Play?
Don't miss out on the next big opportunity! Stay ahead of the curve with ProPicks AI – 6 model portfolios fueled by AI stock picks with a stellar performance this year... In 2024 alone, ProPicks AI identified 2 stocks that surged over 150%, 4 additional stocks that leaped over 30%, and 3 more that climbed over 25%. That's an impressive track record. With portfolios tailored for Dow stocks, S&P stocks, Tech Stocks, and Mid Cap stocks, you can explore various wealth-building strategies. So if ICUI is on your watchlist, it could be very wise to know whether or not it made the ProPicks AI lists.
Unlock ProPicks AI now